Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Leukemia, Myeloid, Acute 45Breast Neoplasms 20Myelodysplastic Syndromes 19Prostatic Neoplasms 12Neoplasms 12Leukemia, Myelomonocytic, Chronic 12Carcinoma, Hepatocellular 10Stomach Neoplasms 9Recurrence 9Carcinoma, Non-Small-Cell Lung 8Neoplasm Metastasis 7Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Sarcoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Ovarian Neoplasms 6Multiple Myeloma 6Lung Neoplasms 6Myeloproliferative Disorders 5Melanoma 5Lymphoma, Non-Hodgkin 5Lymphoma, B-Cell 5Esophageal Squamous Cell Carcinoma 5Colorectal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Biphenotypic, Acute 4Leukemia 4Cholangiocarcinoma 4

Interventions

Cyclophosphamide 27fludarabine phosphate 26Mycophenolic Acid 22Tacrolimus 17Busulfan 17Antilymphocyte Serum 17Peripheral Blood Stem Cell Transplantation 16Whole-Body Irradiation 15Methotrexate 15Melphalan 15Filgrastim 15Cyclosporine 15thymoglobulin 10fludarabine 10Methylprednisolone 9Thiotepa 8Radiotherapy 8Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 7Cytarabine 7Cord Blood Stem Cell Transplantation 7Etoposide 6Clofarabine 6Rituximab 5Sirolimus 4Antibodies 4Alemtuzumab 4Flow Cytometry 3Azacitidine 3merphos 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Myelomonocytic, Juvenile × Injections × Clear all
NCT05849662 2026-04-15

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1/2 Recruiting
58 enrolled
CNSOther hematologic neoplasm

Neurofibromatosis 1, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡